Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Oncotelic Therapeutics, Inc. issued each Note convertible into up to 250,000 shares of Oncotelic's Common Stock of convertible note to 21 accredited investors for conversion price $0.10 per share.
- Security
- convertible note
- Shares
- each Note convertible into up to 250,000 shares of Oncotelic's Common Stock
- Purchaser
- 21 accredited investors
- Consideration
- conversion price $0.10 per share
Exact text from the filing
Each Note will be convertible into up to 250,000 shares of Oncotelic's Common Stock (conversion price $0.10 per share)
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Oncotelic Therapeutics, Inc. issued 250,000 Warrants per Unit of warrant to 21 accredited investors.
- Security
- warrant
- Shares
- 250,000 Warrants per Unit
- Purchaser
- 21 accredited investors
Exact text from the filing
Each Unit will also consist of 250,000 (the "Warrants") each to purchase one share of Oncotelic's Common Stock at $0.12 per share
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Oncotelic Therapeutics, Inc. issued 32 units of unit to 21 accredited investors for $25,000.00 per Unit.
- Security
- unit
- Shares
- 32 units
- Purchaser
- 21 accredited investors
- Consideration
- $25,000.00 per Unit
Exact text from the filing
) unit s (th e “Units” ) bein g conducte d b y Maker . Each Unit consists of one note issued by the Company (a “Note” and collectively, the “Notes”), in the principal amount of $25,000.00, bearing annual interest at the rate of 12% and due and payable on the 2-year anniversary of the final closing of the Offering. Each Note will be convertible into up to 250,000
View on SEC.gov